Abstract
Aim
The aim of this study is to compare the improvements in irritative versus obstructive symptoms of the International Prostate Symptom Score (IPSS) after prostatic artery embolization (PAE) in patients with benign prostatic hyperplasia (BPH).
Materials and Methods
Between 2010 and 2018, 186 patients underwent PAE in a single center and 174 patients were retrospectively selected. The inclusion criteria were symptoms due to BPH, refractory to pharmacological treatment and IPSS ≥ 8. The mean age of the patients was 63.7 ± 7.2 years, the mean prostate volume 89.5 ± 42.5 cm3, and the mean IPSS 19.0 ± 6.2 points. Patient data were reviewed at baseline, 3, 12 and 24 months and compared using the ANOVA mixed models and the Tukey’s multiple comparison test.
Results
Obstructive subscores dropped more significantly than irritative subscores (p < 0.0001). The mean decrease in each IPSS item was frequency 2.4 (83%); urgency 0.8 (87%); nocturia 1.3 (49%); incomplete emptying 2.6 (83%); intermittency 2.3 (91%); weak stream 2.9 (82%); straining 1.6 (91%). The area under the curve for baseline obstructive scores was 0.7 (p = 0.006) and 0.59 (p = 0.182) for irritative scores. The most common BPH clinical manifestations include irritative and/or obstructive symptoms, the latter usually more prevalent. The IPSS drop observed after PAE suggests that it acts predominantly over obstructive symptoms (p < 0.0001).
Conclusion
Although a predominant improvement in obstructive symptoms may be observed after PAE, nocturia complaints may require special attention. The severity of baseline obstructive symptoms may significantly predict clinical outcomes.
Similar content being viewed by others
References
Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549–53.
Liao C-H, Kuo H-C. Measurement of international prostate symptom score subscores. Incont Pelvic Floor Dysfunc. 2010;4(2):39–43.
de la Rosette JJ, Witjes WP, Schäfer W, Abrams P, Donovan JL, Peters TJ, Millard RJ, Frimodt-Møller C, Kalomiris P. Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-”BPH” study. Neurourol Urodyn. 1998;17(2):99–108.
Cockett AT, Aso Y, Denis L et al. (1993) Recommendations of the international consensus committee concerning: 1. Prostate Symptom Score (I-PSS) and quality of life assessment, 2. Diagnostic work-up of patients presenting with symptoms suggestive of prostatism, 3. Standardization of the evaluation of treatment modalities, 4. BPH treatment recommendations. In: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds) The 2nd International consultation on benign prostatic hyperplasia (BPH), Paris, June 27–30, 1993, Proceedings. Scientific Communication International Ltd, Jersey, Channel Islands, pp 553–564.
Oelke M, Baard J, Wijkstra H, de la Rosette JJ, Jonas U, Höfner K. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol. 2008;54(2):419–26.
Madersbacher S, Pycha A, Klingler CH, Schatzl G, Marberger M. The International Prostate Symptom score in both sexes: a urodynamics-based comparison. Neurourol Urodyn. 1999;18(3):173–82.
Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM. Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol. 2016;27(11):1686–97.
Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, Modi S, Dyer J, Harris M, Carolan-Rees G, Hacking N. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122(2):270–82. https://doi.org/10.1111/bju.14249Epub 2018 May 6.
de Assis AM, Moreira AM, de Paula Rodrigues VC, Yoshinaga EM, Antunes AA, Harward SH, Srougi M, Carnevale FC. Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study. J Vasc Interv Radiol. 2015;26(1):87–93.
Agresti A. Categorical data analysis. New York: Wiley; 1990. p. 558p.
Conover WJ. Practical nonparametric statistics. New York: Wiley; 1980.
Neter J, Wasserman W, Kutner MH. Applied linear statistical models. 3rd ed. Illinois: Homewood; 1990.
Winer BJ. Statistical principles in experimental designs. 2ª ed. New York: McGraw-Hill; 1971. p. 907p.
Malling B, Røder MA, Brasso K, Forman J, Taudorf M, Lönn L. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Radiol. 2019;29(1):287–98.
Kuang M, Vu A, Athreya S. A systematic review of prostatic artery embolization in the treatment of symptomatic benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2017;40(5):655–63.
Pisco JM, Rio TH, Campos PL, Bilhim T, Duarte M, Fernandes L, Pereira J, Oliveira A. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23(9):2561–72.
Wang MQ, Wang Y, Yan JY, Yuan K, Zhang GD, Duan F, Li K. Prostatic artery embolisation for the treatment of symptomatic benign prostatic hyperplasia in men ≥ 75 years: a prospective single-center study. World J Urol. 2016;34:1275–83.
Maclean D, Kong M, Lim J, Modi S, Harris M, Bryant T, Hacking N. Does prostate artery embolization (PAE) improve obstructive symptoms, irritative symptoms, or both? Cardiovasc Interv Radiol. 2019. https://doi.org/10.1007/s00270-019-02298-3.
Dmochowski RR. Bladder outlet obstruction: etiology and evaluation. Rev Urol. 2005;7(Suppl 6):S3–13.
Sun F, Sánchez FM, Crisóstomo V, Lima JR, Luis L, García-Mar-tínez V, López-Sánchez C, Usón J, Maynar M. Benign prostatic hyperplasia: transcatheter arterial embolization as potential treatment-preliminary study in pigs. Radiology. 2008;246(3):783–9.
Rosier P. Contemporary diagnosis of lower urinary tract dysfunction [version 1; peer review: 2 approved]. F1000Research. 2019;8(1000):644.
McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE Jr, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793–803.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Moreira, A.M., de Assis, A.M., Carnevale, F.C. et al. Improvements in Irritative Versus Obstructive Symptoms of the International Prostate Symptom Score After Prostatic Artery Embolization in 174 Patients, in a Single Center. Cardiovasc Intervent Radiol 43, 613–619 (2020). https://doi.org/10.1007/s00270-019-02398-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-019-02398-0